Fanconi Syndrome Due to Deferasirox
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference18 articles.
1. New strategies in the treatment of the thalassemias;Schrier;Annu Rev Med,2005
2. Absolute oral bioavailability and disposition of deferasirox in healthy human subjects;Sechaud;J Clin Pharmacol,2008
3. Ethical issues and risk/benefit assessment of iron chelation therapy: Advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox;Kontoghiorghes;Hemoglobin,2008
4. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes;Jabbour;Cancer,2008
5. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: New data, new questions;Neufeld;Blood,2006
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload;Hemoglobin;2024-01-02
2. Nephrological Complications in Hemoglobinopathies: SITE Good Practice;Journal of Clinical Medicine;2023-12-02
3. The pathophysiology of hypophosphatemia;Best Practice & Research Clinical Endocrinology & Metabolism;2023-11
4. Iron Chelators in Treatment of Iron Overload;Journal of Toxicology;2022-05-05
5. The Impact of Iron Chelators on the Biology of Cancer Stem Cells;International Journal of Molecular Sciences;2021-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3